Dr. Syed Anees Medicine Professional Corporation | Windsor, Canada

Research site

(Unclaimed)

Location

2475 Dougall Avenue Suite 2, Windsor, Ontario, Canada

Site insights

Top conditions

Top treatments

BI 1015550

Brenipatide

Povorcitinib

CC-90001

Dupilumab

LY3537031

CSL312

PF-07275315

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 12 total trials

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast (FIBRONEER™-ON)

This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have c...

Enrolling

Progressive Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Drug: Nerandomilast

Locations recently updated

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) (RENEW-COPD)

The main purpose of this study is to assess if different dose levels of Brenipatide are safe and work the way they are intended to work in participan...

Not yet enrolling

Pulmonary Disease, Chronic Obstructive

Drug: Placebo

Drug: Brenipatide

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma (RENEW-Asthma)

The purpose of this study is to assess the safety and efficacy of brenipatide at different dose levels compared with placebo in participants with mod...

Enrolling

Asthma

Drug: Brenipatide

Drug: Placebo

A Study to Evaluate Solrikitug in Participants With COPD (ZION)

A Randomized, Double-blind, Placebo-controlled, Multiple Dose-Ranging Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic...

Active, not recruiting

COPD

Other: Placebo

Biological: Biological: Solrikitug high dose

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

Active, not recruiting

Moderate to Severe Asthma

Drug: ICS-LABA

Other: placebo

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. CO...

Enrolling

Moderate to Severe Chronic Obstructive Pulmonary Disease

Drug: Placebo

Drug: PF-07275315-dose 2

Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma (AIM4:Next Step)

This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condition where the air...

Active, not recruiting

Asthma

Drug: dupilumab

Drug: Matching Placebo